Picture of Litigation Capital Management logo

LIT Litigation Capital Management News Story

0.000.00%
gb flag iconLast trade - 00:00
FinancialsHighly SpeculativeMicro CapValue Trap

REG - Litigation Cap. Mgmt - Interim results for the HY ended 31 December 2025

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260331:nRSe6829Ya&default-theme=true

RNS Number : 6829Y  Litigation Capital Management Ltd  31 March 2026

31 March 2026

 

Litigation Capital Management Limited

("LCM" or the "Company")

 

Interim results for the half year ended 31 December 2025

 

Litigation Capital Management Limited, an alternative asset manager
specialising in dispute financing solutions internationally, today announces
its interim results for the half year ended 31 December 2025.

 

Commenting on the results, Patrick Moloney, CEO of Litigation Capital
Management, said: "The first half of this financial year has been the most
challenging period in LCM's history. We experienced a number of large case
losses which resulted in a significant financial loss for shareholders. In
September 2025 we commenced a Strategic Review to explore all options for
restoring LCM's balance sheet strength and realising value for shareholders.
The Strategic Review is now approaching a conclusion and we will communicate
its outcome to shareholders as soon as we are able to."

 

LCM will be hosting a webinar for investors today at 9.00 a.m. The
presentation is open to all existing and potential shareholders. If you would
like to attend this presentation, please register using the following link:

https://www.investormeetcompany.com/litigation-capital-management-limited/register-investor
(https://www.investormeetcompany.com/litigation-capital-management-limited/register-investor)

 

The accompanying results presentation is available on LCM's website:

https://www.lcmfinance.com/investors/investor-presentations-results
(https://www.lcmfinance.com/investors/investor-presentations-results)

 

The Interim Financial Report is available at:

https://www.lcmfinance.com/investors/investor-presentations-results
(https://www.lcmfinance.com/investors/investor-presentations-results%20)

 

Enquiries

 

 Litigation Capital Management
 Patrick Moloney, Chief Executive Officer

 David Collins, Chief Financial Officer

 Cavendish (Nomad and Broker)                               Tel: 020 7220 0500
 Jonny Franklin-Adams and Isaac Hooper (Corporate Finance)

 Ella Bedford (Corporate Broking)

 

NOTES TO EDITORS

Litigation Capital Management (LCM) is an alternative asset manager
specialising in disputes financing solutions internationally, which operates
two business models. The first is direct investments made from LCM's permanent
balance sheet capital and the second is third party fund management. Under
those two business models, LCM currently pursues three investment strategies:
Single-case funding, Portfolio funding and Acquisitions of claims. LCM
generates its revenue from both its direct investments and also performance
fees through asset management.

 

Currently headquartered in Sydney, with offices in London, Singapore, Brisbane
and Melbourne, LCM listed on AIM in December 2018, trading under the ticker
LIT.

 

www.lcmfinance.com (http://www.lcmfinance.com)

 

 

Chief Executive's Statement

The half year to 31 December 2025 proved exceptionally difficult for
Litigation Capital Management Limited ("LCM" or the "Company"). A series of
large case losses has led to substantial financial losses for shareholders.
Such outcomes underline the binary and concentrated risks that are fundamental
to litigation finance, where just a few high-value investments can produce
disproportionately adverse results when they meet unfavourable judgments.

These results mark a significant departure from LCM's long-term track
record-one built on disciplined case selection, rigorous portfolio management,
and the consistent delivery of positive cumulative returns over many years.

LCM is not alone in grappling with these difficulties. Many of our peers have
encountered comparable pressures in recent years, and several have ceased
operations as a result. These widespread challenges make it evident that the
industry must make fundamental changes to strengthen risk assessment, refine
portfolio construction, and, in turn, deliver improved returns to capital
providers.

To address our challenges, we have taken the following actions:

·      Launched a Strategic Review in September 2025 to explore all
options for restoring LCM's balance sheet strength and realising value for
shareholders.

·      Secured debt covenant waivers from our lender, providing
operational flexibility and stability while longer-term solutions are pursued.

·      Undertaken a comprehensive re-underwriting of the existing case
portfolio, with targeted decisions applied to challenged investments,
including selective exits, to protect remaining value and reduce future risk
exposure.

The Strategic Review continues as the Board's central priority. This process
is advancing steadily, with the Board fully committed to identifying and
executing the most appropriate path forward in the interests of all
stakeholders.

We remain deeply grateful for the patience and ongoing support of our
shareholders, lenders, and other stakeholders during this challenging period.
The Company will issue further updates in due course, particularly regarding
the conclusion and outcome of the Strategic Review.

Patrick Moloney

Chief Executive Officer

31 March 2026

 

 

 

 

 

 

 

Directors' Report

 

The Directors of Litigation Capital Management Limited (LCM) present their
report together with the half-year financial report of the consolidated entity
consisting of LCM and its subsidiaries (collectively LCM Group or the Group)
for the six month period ended 31 December 2025 and the auditors' review
report thereon.

1. Directors

The Directors of LCM at any time during or since the end of the financial
period are set out below:

Jonathan Moulds

Patrick Moloney

Dr David King

David Collins

 

2. Company Secretary

Anna Sandham was appointed Company Secretary of LCM in September 2016. Anna is
an experienced company secretary and governance professional with over 20
years' experience in various large and small, public and private, listed and
unlisted companies. Anna has previously worked for companies including AMP
Financial Services, Westpac Banking Corporation, BT Financial Group and NRMA
Limited. Anna holds a Bachelor of Economics (University of Sydney), Graduate
Diploma of Applied Corporate Governance (Governance Institute of Australia)
and is a Chartered Secretary.

3. Principal activities

LCM is a global provider of disputes finance and risk management services.

Headquartered in Sydney, with offices in London, Singapore, Brisbane and
Melbourne, LCM listed on AIM in December 2018, trading under the ticker LIT.

4. Operating and financial review

Overview of the LCM Group

LCM is a company limited by shares and was incorporated on 9 October 2015. LCM
was admitted to trade on the Alternative Investment Market (AIM) of the London
Stock Exchange on 19 December 2018 under the ticker LIT. LCM was formerly
listed on the Australian Securities Exchange (ASX) between 13 December 2016
and 21 December 2018.

Its registered office and principal place of business is Level 12, The Chifley
Tower, 2 Chifley Square, Sydney NSW 2000, Australia.

Operations

LCM operates its business through a series of wholly owned subsidiaries. The
principal activity of those subsidiaries is the provision of litigation
finance and risk management associated with individual and portfolios of
disputes. LCM currently operates two business models.  The first is direct
investments made from LCM's balance sheet capital.  The second is funds
and/or asset management. Under those two business models, LCM currently
pursues three investment strategies.  Those strategies are as follows:

Single‐case funding: The first and currently largest strategy, is
single‐case funding.  That is, the investment in a single dispute.  This
is a strategy that LCM has maintained since its inception (through its
predecessor company) 25 years ago.  Currently, a large proportion of LCM's
investments are in single‐case investments.

Portfolio funding: The second strategy pursued by LCM is portfolio funding.
That is, the provision of a portfolio based funding solution to law firms,
insolvency practitioners or corporates.  It involves the provision of a
financing solution and risk management tools for a bundle of separate
disputes.  LCM's particular focus with respect to that strategy is the
provision of corporate portfolio financing.

Acquisitions of Claims: The third strategy, in its early stages of evolution,
is the investment in smaller disputes (typically insolvency‐based) through
the acquisition or assignment of the underlying cause of action. LCM generates
its revenue through acquiring a cause of action and pursuing a recovery or
award as principal.

 

Review of financial performance

The statutory loss for the Group after adjusting for income tax amounted to
$107,767,000 (31 December 2024: $8,353,000). Operating loss before tax is
$111,672,000 (31 December 2024: $7,952,000).

Cash on balance sheet was $23,601,000 as at 31 December 2025 (30 June 2025:
$18,447,000). Of this, $22,207,000 relates to third-party cash which is
restricted cash as it relates to balances held within the fund investment
vehicles which have been consolidated with the Group numbers (30 June 2025:
$9,582,000). Cash generated during the period from the resolution of
investments was $1,428,000 (31 December 2024: $56,402,000).

The Directors do not recommend a dividend in respect of the period ended 31
December 2025.

 

5. Matters subsequent to the end of the financial period

On 12 January 2026, the Group announced a positive development in its
international arbitration claim against the Republic of Poland, where the
Singapore court rejected Poland's application to set aside the Energy Charter
Treaty award.

On 2 February 2026, the Group announced an increase in its credit facility
together with an extension of the debt covenant waiver from its lender.

On 11 March 2026, the Group announced that its funded party had been
successful in the High Court of Australia in a trademark dispute claim in
which LCM had invested A$3.3 million. The matter will now proceed to the Full
Court for the quantification of costs and damages.

On 17 March 2026, the Group announced that an adverse judgment had been
delivered in an Australian commercial litigation claim funded by the Group
with A$1.4 million of shareholder capital. The Group is reviewing the judgment
and considering its options.

The Strategic Review, which was commenced in September 2025, continues to
progress.

6. Lead Auditor's independence declaration

The Auditor's independence declaration as required under section 307C of the
Corporations Act 2001 is included in LCM's financial statements.

7. Rounding of amounts

LCM is of a kind referred to the Australian Securities and Investments
Commission Corporations (Rounding in Financial/Directors' Reports) Instrument
2016/191, relating to 'rounding-off'. Amounts in this report have been rounded
off in accordance with that Instrument to the nearest thousand dollars, or in
certain cases, the nearest dollar.

Signed in accordance with a resolution of directors, pursuant to section
306(3)(a) of the Corporations Act 2001.

 

 

Mr Jonathan Moulds

Chairman

31 March 2026

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Consolidated statement of profit or loss and other comprehensive income

For the period ended 31 December 2025

 

                                                                                                Consolidated
                                                                                                31 Dec 2025                     31 Dec 2024
                                                                        Note                    $'000                           $'000

 Income
 Net realised gain on investments                                       4                       (26,540)                        93,439
 Net unrealised gain/(loss) on investments                              4                       (99,191)                        (67,650)
 Movement in financial liabilities related to third-party interests in  4                       51,098                          (18,382)
 consolidated entities
 Litigation service revenue                                             4                       -                               -
 Litigation service expense                                             5                       (31,126)                        -
 Total income/(loss)                                                                            (105,759)                       7,408

  Expenses
  Employee benefits expense                                             5                       (4,412)                         (6,688)
  Depreciation expense                                                  5                       (36)                            (47)
  Corporate expenses                                                    5                       (1,606)                         (2,577)
  Fund administration expense                                           5                       (545)                           (1,313)
  Foreign currency gains/(losses)                                       5                       686                             (4,735)
  Total operating expenses                                                                                              (5,913)         (15,360)
 Operating loss                                                                                 (111,672)                       (7,952)
  Finance costs                                                         5                       (4,604)                         (3,710)
 Loss before income tax expense                                                                                         (116,276)       (11,662)
  Income tax benefit                                                    6                       8,509                           3,309
 Loss after income tax expense                                                                                          (107,767)       (8,353)

 Other comprehensive income
 Items that may be subsequently reclassified to profit and loss:
 Movement in foreign currency translation reserve                                                                       (1,383)         8,620
 Total comprehensive income for the period                                                                              (109,150)       267

 Loss for the period is attributable to:
 Owners of Litigation Capital Management Limited                                                                        (107,767)       (8,353)
                                                                                                (107,767)                       (8,353)
 Total comprehensive income for the period is attributable to:
 Owners of Litigation Capital Management Limited                                                                        (109,150)       267
                                                                                                (109,150)                       267

                                                                                                Cents                           Cents

 Basic loss per share                                                   7                       (104.73)                        (8.09)
 Diluted loss per share                                                 7                       (104.73)                        (8.09)

 

 

The above Consolidated Statement of Profit or Loss and Other Comprehensive
Income should be read in conjunction with accompanying Notes to the Financial
Statements.

 

 

 

 

 

 

 

 

 

Consolidated statement of financial position

For the period ended 31 December 2025

 

                                                                                          Consolidated
                                                                                          31 Dec 2025  30 Jun 2025
                                                                         Note             $'000        $'000

 Assets
 Cash and cash equivalents                                               8                23,601       18,447
 Trade receivables                                                       9                1,786        1,786
 Due from resolution of financial assets                                 10               87,003       88,201
 Contract costs                                                          11               19,037       47,988
 Investments                                                             12               203,729      287,735
 Property, plant and equipment                                                            129          135
 Intangible assets                                                                        410          439
 Other assets                                                                             1,357        827
 Total assets                                                                             337,052      445,558

 Liabilities
 Trade and other payables                                                13               23,672       10,508
 Tax payable/(refund)                                                                     (26)         (6)
 Employee benefits                                                                        1,183        1,115
 Borrowings                                                              14               93,790       77,747
 Financial liabilities related to third-party interests in consolidated  15               206,046      226,538
 entities
 Deferred tax liability                                                                   6,777        15,286
 Total liabilities                                                                        331,442      331,188
 Net assets                                                                               5,610        114,370

 Equity
 Issued capital                                                          16               61,286       60,634
 Reserves                                                                                 7,192        8,838
 Retained earnings                                                                        (62,868)     44,899
 Parent interest                                                                          5,610        114,370
 Total equity                                                                             5,610        114,370

 

 

The above Consolidated Statement of Financial Position should be read in
conjunction with accompanying Notes to the Financial Statements.

 

 

 

 

 

 

Consolidated statement of changes in equity

For the period ended 31 December 2025

 

 

                                                Issued capital                                                                  Treasury shares                                                                   Retained earnings                                                        Share based payments reserve                                                    Foreign currency translation                                                       Total equity
 Consolidated                                   $'000                                                                           $'000                                                                             $'000                                                                    $'000                                                                           $'000                                                                              $'000
 Balance at 1 July 2024                                                       69,674                                                                                                                                                                                                                                          3,556                                                                              615                                                                             188,941
                                                                                                                                (5,396)                                                                           120,492
 Loss after income tax expense for the period   -                                                                               -                                                                                 (8,353)                                                                  -                                                                               -                                                                                  (8,353)
 Other comprehensive income for the period      -                                                                               -                                                                                 -                                                                        -                                                                               8,620                                                                              8,620
 Total comprehensive income for the period      -                                                                               -                                                                                 (8,353)                                                                  -                                                                               8,620                                                                              267

 Equity Transactions:
 Share-based payments (note 20)                                                        -                                                                                                                                                                                                                                         590
                                                                                                                                -                                                                                 -                                                                                                                                                        -                                                                                                                         590
 Dividends paid (note 17)                       -                                                                               -                                                                                 (2,680)                                                                  -                                                                               -                                                                                  (2,680)
 Treasury shares acquired (note 16)             -                                                                               (4,458)                                                                           -                                                                        -                                                                               -                                                                                  (4,458)
 Cancellation of treasury shares (note 16)      (9,854)                                                                         9,854                                                                             -                                                                        -                                                                               -                                                                                  -
 LSPs exercised and purchased by EBT (note 16)  (860)                                                                           -                                                                                 -                                                                        -                                                                               -                                                                                  (860)
                                                (10,714)                                                                        5,396                                                                             (2,680)                                                                  590                                                                             -                                                                                  (7,407)
 Balance at 31 December 2024                                                  58,960                                                                                 -                                                                                                                                                        4,146                                                                                                                                                              181,800
                                                                                                                                                                                                                  109,459                                                                                                                                                  9,235

 

 

 

                                               Issued capital                                                                Treasury shares                                                                   Retained earnings                                                        Share based payments reserve                                                Foreign currency translation                                                       Total equity
 Consolidated                                  $'000                                                                         $'000                                                                             $'000                                                                    $'000                                                                       $'000                                                                              $'000
 Balance at 1 July 2025                                                      60,634                                                                               -                                                                                                                                                        3,094                                                                                                                                                          114,370
                                                                                                                                                                                                               44,899                                                                                                                                               5,744
 Loss after income tax expense for the period  -                                                                             -                                                                                 (107,767)                                                                -                                                                           -                                                                                  (107,767)
 Other comprehensive income for the period     -                                                                             -                                                                                 -                                                                        -                                                                           (1,383)                                                                            (1,383)
 Total comprehensive income for the period     -                                                                             -                                                                                 (107,767)                                                                -                                                                           (1,383)                                                                            (109,150)

 Equity Transactions:
 Share-based payments (note 20)
                                               652                                                                           -                                                                                 -                                                                        (264)                                                                       -                                                                                  389
                                               652                                                                           -                                                                                 -                                                                        (264)                                                                       -                                                                                  389
 Balance at 31 December 2025                                                 61,286                                                                               -                                                                                                                                                        2,830                                                                                                                                                          5,610
                                                                                                                                                                                                               (62,868)                                                                                                                                             4,361

 

 

The above Consolidated Statement of Changes in Equity should be read in
conjunction with accompanying Notes to the Financial Statements.

 

 

 

 

 

 

 

Consolidated statement of cash flows

For the period ended 31 December 2025

 

                                                                                                     Consolidated
                                                                                                     31 Dec 2025  31 Dec 2024
                                                                    Note                             $'000        $'000

 Cash flows from operating activities
 Proceeds from litigation contracts                                                                  1,428        56,402
 Payments for litigation contracts                                                                   (40,059)     (78,310)
 Payments to suppliers and employees                                                                 (7,249)      (10,152)
 Income tax paid                                                                                     -            (28)
 Net cash used in operating activities                                                               (45,880)     (32,088)

 Cash flows from investing activities
 Payments for property, plant and equipment                                                          -            (3)
 Payments for intangibles                                                                            -            (179)
 Refund/(payment) of security deposits                                                               14           (1)
 Net cash from/(used in) investing activities                                                        14           (182)

 Cash flows from financing activities
 Payments for treasury and loan shares                                                               -            (5,318)
 Dividends paid                                                     17                               -            (2,607)
 Proceeds from borrowings                                           14                               15,666       -
 Repayments of borrowings                                           14                               -            (11,358)
 Payments of finance costs                                                                           (2,696)      (3,186)
 Payments of placement fees related to third-party interests                                         -            (835)
 Contributions from third-party interests in consolidated entities  15                               38,145       40,626
 Distributions to third-party interests in consolidated entities    15                               -            (24,572)
 Net cash from/(used in) financing activities                                                        51,116       (7,250)

 Net decrease in cash and cash equivalents                                                           5,250        (39,519)
 Cash and cash equivalents at the beginning of the period                                            18,447       68,113
 Effects of exchange rate changes on cash and cash equivalents                                       (95)         1,991
 Cash and cash equivalents at the end of the period                 8                                23,601       30,585

 

 

The above Consolidated Statement of Cash Flows should be read in conjunction
with accompanying Notes to the Financial Statements.

 

 

 

Notes to the financial statements

31 December 2025

 

Note 1. General information

 

The financial statements cover Litigation Capital Management Limited (the
'Company') as a Group consisting of Litigation Capital Management Limited and
the entities it controlled at the end of, or during, the period (referred to
as the 'Group'). The financial statements are presented in Australian dollars,
which is Litigation Capital Management Limited's functional and presentation
currency.

 

Litigation Capital Management Limited was admitted onto the Alternative
Investment Market ('AIM') on 19 December 2018.

 

Litigation Capital Management Limited is a for profit publicly listed company
limited by shares, incorporated and domiciled in Australia. Its registered
office and principal place of business is:

 

Level 12, The Chifley Tower

2 Chifley Square

Sydney NSW 2000

 

A description of the nature of the Group's operations and its principal
activities are included in the Directors' report, which is not part of the
financial statements.

 

The financial statements were authorised for issue, in accordance with a
resolution of Directors, on30 March 2026. The Directors have the power to
amend and reissue the financial statements.

 

Note 2. Material accounting policies

 

These consolidated financial statements are general purpose financial
statements for the interim reporting period ended 31 December 2025 and have
been prepared in accordance with the Corporations Act 2001 and Australian
Accounting Standard AASB 134 Interim Financial Reporting. Compliance with AASB
134 ensures compliance with International Financial Reporting Standard IAS 34
'Interim Financial Reporting'.

 

These interim financial statements do not include all the notes of the type
normally included in annual financial statements. Accordingly, these financial
statements are to be read in conjunction with the annual report for the year
ended 30 June 2025 and any public announcements made by the Company during the
interim reporting period.

 

Basis of preparation

 

The principal accounting policies adopted are consistent with those of the
previous financial year and corresponding interim reporting period, unless
otherwise stated.

 

Accounting standards and interpretations

The accounting policies adopted are consistent with those followed in the
preparation of the Group's annual consolidated financial statements for the
year ended 30 June 2025.

 

New and amended accounting standards and interpretations issued but not yet
effective

The new and amended standards and interpretations that are issued, but not yet
effective, up to the date of issuance of the Group's financial statements that
the Group reasonably expects will have an impact on its disclosures, financial
position or performance when applied at a future date, are disclosed below.

 

• Amendment to IFRS 9 and IFRS 7 - Classification and Measurement of
Financial Instruments

• IFRS 18 Presentation and Disclosure in Financial Statements

• IFRS 19 Subsidiaries without Public Accountability: Disclosures

• IFRS S1, General requirements for disclosure of sustainability-related
financial information

• IFRS S2 Climate-related disclosures

 

The Group intends to adopt these new and amended standards and
interpretations, if applicable, when they become effective. The Group has not
listed other standards and interpretations which are issued but not yet
effective, as they are not expected to impact the Group.

 

Historical cost convention

The financial statements have been prepared under the historical cost
convention.

 

Critical accounting estimates

The critical accounting judgements, estimates and assumptions that have been
applied in the preparation of the interim consolidated financial statements
are consistent with those followed in the preparation of the Group's annual
report for the year ended 30 June 2025.

 

Going concern

The financial statements have been prepared on the going concern basis, which
contemplates continuity of normal business activities and the realisation of
assets and discharge of liabilities in the normal course of business.

 

The Company is currently reliant on covenant waivers from its lender, funds
managed by Northleaf Capital Partners (Canada) Ltd. To date, these waivers
have been forthcoming and have covered the quarters ending 30 June 2025, 30
September 2025 and 31 December 2025 (with extensions granted progressively,
the most recent extending coverage to 15 April 2026).

 

The lender has continued to provide these waivers while the Company has been
conducting a Strategic Review process, announced on 15 September 2025, with
the objective of restoring the Company's financial strength. This review is
evaluating a range of options to strengthen the balance sheet and is being
undertaken in constructive dialogue with the lender, who has also been
evaluating the options available to it as lender.

 

While the Company's lender has been supportive in granting covenant waivers to
date, any further extensions or amendments that may be required in future
periods will remain subject to the outcome of its own evaluation, the
intentions of the Company's lender which may change at any time and any
actions taken as a result thereof.

 

After considering the Company's forecasts, stress testing, available
mitigating actions (including progress under the Strategic Review), and having
regard to the inherent risks associated with the binary nature of the
Company's investment model, the Directors have concluded that a material
uncertainty exists which may cast significant doubt on the Company's ability
to continue as a going concern.

 

The material uncertainty primarily relates to the Company's ability to
maintain ongoing compliance with its debt covenants or to continue to obtain
the necessary waivers from its lender in light of the result of the
evaluations referred to above. The Directors have a reasonable expectation
that the Company will continue to receive the necessary support from its
lender to allow it to continue in operational existence for the foreseeable
future. Accordingly, the financial statements have been prepared on a going
concern basis, whilst noting the material uncertainty described above.

 

However, these events and conditions indicate that a material uncertainty
exists which may cast significant doubt on the Company's ability to continue
as a going concern, and therefore the entity may be unable to realise its
assets and discharge its liabilities in the normal course of business and at
the amounts stated in the financial report. The financial report does not
include any adjustments relating to the amounts or classification of recorded
assets or liabilities that might be necessary if the Company does not continue
as a going concern.

Note 3. Segment information

 

For management purposes, the Group is organised into two operating segments
comprising the operations of Litigation Capital Management Limited and its
wholly owned subsidiaries ("LCM") and the Group's fund structures ("Fund").

 

LCM

The LCM column includes the 25% co-investment in the Funds, Balance Sheet
investments (ie, 100% investment by LCM) and corporate operations.

 

Fund I & II

This comprises LCM Global Alternative Returns Fund and LCM Global Alternative
Returns Fund II and their entities as disclosed in note 27 of the annual
report for the year ended 30 June 2025. AASB 10 Consolidated Financial
Statements requires the Group to consolidate fund investment vehicles over
which it has exposure to variable returns from the fund investment vehicles.
As a result, third party interests in relation to the Funds have been
consolidated in the financial statements. The Fund column includes the 75%
co-investment in the litigation funding assets and costs of administering the
funds.

 

The following tables reflect the impact of consolidating the results of the
Funds with the results for LCM to arrive at the totals reported in the
consolidated statement of profit or loss and other comprehensive income,
consolidated statement of financial position and consolidated statement of
cash flows.

 

 

 

Consolidated Statement of Comprehensive Income

 

                                                                        31 December 2025                             31 December 2024
                                                                        LCM        Fund      Consolidated  LCM       Fund      Consolidated
                                                                        $'000      $'000     $'000         $'000     $'000     $'000
 Income
 Net realised gain on investments                                       (13,105)   (13,434)  (26,540)      37,429    56,010    93,439
 Net unrealised gain/(loss) on investments                              (61,496)   (37,694)  (99,191)      (32,750)  (34,899)  (67,650)
 Movement in financial liabilities related to third-party interests in  -          51,098    51,098        -         (18,382)  (18,382)
 consolidated entities
 Litigation service revenue                                             -          -         -             -         -         -
 Litigation service expense                                             (31,126)   -         (31,126)      -         -         -
 Total income/(loss)                                                    (105,728)  (30)      (105,759)     4,679     2,729     7,408

 Expenses
 Employee benefits expense                                              (4,412)    -         (4,412)       (6,688)   -         (6,688)
 Depreciation expense                                                   (36)       -         (36)          (47)      -         (47)
 Corporate expenses                                                     (1,606)    -         (1,606)       (2,577)   -         (2,577)
 Fund administration expense                                            -          (545)     (545)         (835)     (478)     (1,313)
 Foreign currency gains/(losses)                                        110        575       686           (2,484)   (2,251)   (4,735)
 Total operating expenses                                               (5,943)    30        (5,913)       (12,632)  (2,729)   (15,360)
 Operating loss                                                         (111,672)  -         (111,672)     (7,952)   -         (7,952)
 Finance costs                                                          (4,604)    -         (4,604)       (3,710)   -         (3,710)
 Loss before income tax expense                                         (116,276)  -         (116,276)     (11,662)  -         (11,662)
  Income tax benefit                                                    8,509      -         8,509         3,309     -         3,309
 Loss after income tax expense                                          (107,767)  -         (107,767)     (8,353)   -         (8,353)

 Other comprehensive income for the period, net of tax                  (1,383)    -         (1,383)       8,620     -         8,620
 Total comprehensive income for the period                              (109,150)  -         (109,150)     267       -         267

 

 

 

 

 

Consolidated statement of financial position

 

                                                            31 December 2025                     30 June 2025
                                                            LCM      Fund          Consolidated  LCM      Fund     Consolidated
                                                            $'000    $'000         $'000         $'000    $'000    $'000

 Assets
 Cash and cash equivalents                                  1,394    22,207        23,601        8,865    9,582    18,447
 Trade & other receivables                                  1,786    -             1,786         1,786    -        1,786
 Due from resolution of financial assets                    21,852   65,151        87,003        28,824   59,377   88,201
 Contract costs                                             19,037   -             19,037        47,988   -        47,988
 Financial assets at fair value through profit or loss      76,150   127,579       203,729       124,839  162,896  287,735
 Property, plant and equipment                              129      -             129           135      -        135
 Intangible assets                                          410      -             410           439      -        439
 Other assets                                               1,309    48            1,356         1,174    (347)    827
 Total assets                                               122,067  214,985       337,052       214,050  231,508  445,558

 Liabilities
 Trade and other payables                                   14,733   8,939         23,672        5,538    4,970    10,508
 Tax payable                                                (26)     -             (26)          (6)      -        (6)
 Employee Benefits                                          1,183    -             1,183         1,115    -        1,115
 Borrowings                                                 93,790   -             93,790        77,747   -        77,747
 Third-party interests in consolidated entities             -        206,046       206,046       -        226,538  226,538
 Deferred tax liability                                     6,777    -             6,777         15,286   -        15,286
 Total liabilities                                          116,458  214,985       331,442       99,680   231,508  331,188
 Net assets                                                 5,610           -      5,610         114,370  -        114,370

 

 

 

 

 

Consolidated Statement of Cash Flows

 

                                                                    31 December 2025                  31 December 2024
                                                                    LCM       Fund      Consolidated  LCM       Fund      Consolidated
                                                                    $'000     $'000     $'000         $'000     $'000     $'000

 Cash flows from operating activities
 Proceeds from litigation contracts                                 1,415     13        1,428         29,227    27,176    56,402
 Payments for litigation contracts                                  (15,535)  (24,524)  (40,059)      (35,372)  (42,938)  (78,310)
 Payments to suppliers and employees                                (6,298)   (951)     (7,249)       (9,579)   (573)     (10,152)
 Income tax paid                                                    -         -         -             (28)      -         (28)
 Net cash from/(used in) operating activities                       (20,419)  (25,461)  (45,880)      (15,752)  (16,335)  (32,088)

 Cash flows from investing activities
 Payments for property, plant and equipment                         -         -         -             (3)       -         (3)
 Payments for intangibles                                           -         -         -             (179)     -         (179)
 Refund/(payment) of security deposits                              14        -         14            (1)       -         (1)
 Net cash used in investing activities                              14        -         14            (182)     -         (182)

 Cash flows from financing activities
 Payments for treasury shares                                       -         -         -             (5,318)   -         (5,318)
 Dividends paid                                                     -         -         -             (2,607)   -         (2,607)
 Proceeds from borrowings                                           15,666    -         15,666        -         -         -
 Repayments of borrowings                                           -         -         -             (11,358)  -         (11,358)
 Payments of finance costs                                          (2,696)   -         (2,696)       (3,186)   -         (3,186)
 Payments of placement fees related to third-party interests        -         -         -             (835)     -         (835)
 Contributions from third-party interests in consolidated entities  -         38,145    38,145        -         40,626    40,626
 Distributions to third-party interests in consolidated entities    -         -         -             -         (24,572)  (24,572)
 Net cash from/(used in) financing activities                       12,971    38,145    51,116        (23,304)  16,054    (7,250)

 Net decrease in cash and cash equivalents                          (7,435)   12,684    5,250         (39,238)  (281)     (39,519)
 Cash and cash equivalents at the beginning of the period           8,865     9,582     18,447        53,024    15,089    68,113
 Effects of exchange rate changes on cash and cash equivalents      (36)      (59)      (95)          1,082     909       1,991
 Cash and cash equivalents at the end of the period                 1,394     22,207    23,601        14,868    15,717    30,585

 

 

 

 

 

 

Note 4. Income

 

                                                                        31 Dec 2025                              31 Dec 2024
                                                                        LCM       Fund      Consolidated  LCM           Fund      Consolidated
                                                                        $'000     $'000     $'000         $'000         $'000     $'000

 Net realised gain on investments
 Recoveries on resolved investments                                     1,094     -         1,094         51,461        97,783    149,244
 Reversal of performance fees previously recognised                     (6,623)   6,623     -             -             -         -
 Capital invested on resolved investments                               (7,577)   (20,057)  (27,635)      (14,032)      (41,772)  (55,804)
                                                                        (13,105)  (13,435)  (26,540)      37,429        56,010    93,439

 Net unrealised gain/(loss) on investments
 Fair value removal on concluded investments                            2,325     7,063     9,389         (34,002)      (37,641)  (71,643)
 Fair value write down on case losses under appeal                      (60,351)  (39,107)  (99,458)      (10,986)      (6,228)   (17,214)
 Fair value movement on pre-hearing/trial ongoing investments(1)        (3,283)   (5,185)   (8,468)                     6,859     18,314

                                                                                                          11,455
 Foreign exchange movement on fair value                                (188)     (465)     (654)         783           2,111     2,894
                                                                        (61,496)  (37,694)  (99,191)      (32,750)      (34,899)  (67,650)
 Total gain/(loss) on investments                                       (74,602)  (51,129)  (125,731)     4,679         21,111    25,789
 Movement in financial liabilities related to third-party interests in  -         51,098    51,098        -             (18,382)  (18,382)
 consolidated entities
 Total income/(loss)                                                    (74,602)  (31)      (74,633)      4,679         2,729     7,408

 

 

Realised gains relate to amounts where litigation risk has concluded and
amounts are expected to be received by LCM. Unrealised gains or losses relate
to the fair value movement of assets and liabilities associated with
litigation contracts. The gain and loss related to third party interests in
consolidated entities represents realised and unrealised gains and losses that
relate to third party funded proportions from LCM controlled entities.

 

 

Litigation service

                                        Consolidated
                                        31 Dec 2025   31 Dec 2024
                                        $'000         $'000

 Litigation service revenue             -             -
 Litigation service expense             (31,126)      -
                                        (31,126)      -
 Major service lines
 Revenue attributable to LCM            -             -
 Attributable to third party interests  -             -
                                        -             -
 Geographical regions
 Australia                              -             -
                                        -             -

 

Litigation service revenue relates to an individual litigation asset which
resolved during the period and had a contract duration of more than 4 years.

 

 

Note 5. Profit/(loss) before tax

                                                                          Consolidated
                                                                          31 Dec 2025  31 Dec 2024
                                                                          $'000        $'000

 Profit/(loss) before income tax expense includes the following specific
 expenses:

 Employee benefits expense
 Salaries & wages                                                         3,342        5,074
 Non-Executive directors' fees                                            180          239
 Superannuation and pension                                               119          156
 Share based payments expense                                             389          495
 Other employee benefits & costs                                          383          725
                                                                          4,412        6,688
 Depreciation
 Plant and equipment                                                      6            16
 Intangible assets                                                        30           31
                                                                          36           47
 Corporate expenses
 Corporate & secretary expenses                                           130          247
 General & Administrative Expenses                                        57           123
 Insurance                                                                96           215
 Marketing & Advertising                                                  21           68
 Occupancy Costs                                                          455          462
 Other expenses                                                           28           38
 Professional fees                                                        397          711
 Travel & entertainment expenses                                          101          465
 Business development expenses                                            13           248
 Strategic review costs                                                   309          -
                                                                          1,606        2,577

 

 Fund administration expense
 General administration expenses             545      478
 Placement fees                              -        835
                                             545      1,313
 Foreign currency gains/(losses)
 Realised foreign exchange loss              2,006    703
 Unrealised foreign exchange gain            (2,692)  4,032
                                             (686)    4,735
 Finance costs
 Net interest on borrowings                  4,475    3,257
 Net finance costs of third-party interests  -        -
 Other finance costs                         129      453
                                             4,604    3,710

 

 

Note 6. Income tax expense

                                                                               Consolidated
                                                                               31 Dec 2025  31 Dec 2024
                                                                               $'000        $'000
 Numerical reconciliation of income tax expense and tax at the statutory rate
 Loss before income tax expense                                                (116,276)    (11,662)

 At the Group's statutory income tax rate of 30% (Dec 2024: 30%)               (34,883)     (3,499)

 Tax effect amounts which are not deductible/(taxable) in calculating taxable
 income:
 Foreign tax rate adjustments                                                  1,391        819
 Share-based payments                                                          (63)         76
 Other assessable income                                                       (212)        -
 Other non-deductible expenses                                                 14,391       368
 Unrealised foreign exchange                                                   -            -
 Change in tax rate                                                            -            -
 Adjustment in respect of income tax                                           7,599        -
 Adjustment in respect of deferred tax of previous years                       3,267        -
 Utilisation of carried forward tax losses                                     -            (1,073)
 Income tax expense / (benefit)                                                (8,509)      (3,309)

 

 

Note 7. Loss per share

 

                                                                                31 Dec 2025  31 Dec 2024
                                                                                $'000        $'000

 Loss after income tax                                                          (107,767)    (8,353)
 Loss after income tax attributable to the owners of Litigation Capital         (107,767)    (8,353)
 Management Limited

                                                                                Number       Number
 Weighted average number of ordinary shares used in calculating basic earnings  102,903,962  103,190,317
 per share(1)
 Adjustments for calculation of diluted earnings per share:
 Amounts uncalled on partly paid shares                                         -            -
 Options over ordinary shares                                                   -            -
 Weighted average number of ordinary shares used in calculating diluted         102,903,962  103,190,317
 earnings per share

 (1) Weighted average number of ordinary shares on issue during the year,
 excludes treasury shares held

                                                                                Cents        Cents
 Basic loss per share                                                           (104.73)     (8.09)
 Diluted loss per share                                                         (104.73)     (8.09)

 

Dilutive potential shares which are contingently issuable are only included in
the calculation of diluted earnings per share where the conditions are met. As
at 31 December 2025, there were 2,111,672 shares calculated for inclusion in
diluted earnings per share, however these were not included due to their
anti-dilutive effect.

 

 

Note 8. Cash and cash equivalents

 

                                                         Consolidated
                                                         31 Dec 2025  30 Jun 2025
                                                         $'000        $'000
 Cash at Bank                                            1,394        8,865
 Cash of third-party interests in consolidated entities  22,207       9,582
                                                         23,601       18,447

 

Cash of third-party interests in consolidated entities is restricted as it is
held within the fund investment vehicles on behalf of the third-party
investors in these vehicles. The cash is restricted to use cashflows in the
litigation funding assets made on their behalf and costs of administering the
fund.

 

 

Note 9. Trade receivables

 

                              Consolidated
                              31 Dec 2025  30 Jun 2025
                              $'000        $'000

 Due from litigation service  1,786        1,786
                               1,786        1,786

 

As at 31 December 2025, trade receivables are expected to be settled within 12
months after the Balance Sheet date.

 

Allowance for expected credit losses

The Group has recognised a loss of $nil (Jun 2025: $nil) in profit or loss in
respect of the expected credit losses for the period ended 31 December 2025.

 

 

Note 10. Due from resolution of investments

 

                                                              31 Dec 2025                           30 Jun 2025
                                                              LCM      Fund    Consolidated  LCM           Fund      Consolidated
                                                              $'000    $'000   $'000         $'000         $'000     $'000

 At start of period                                           28,824   59,377  88,201        3,980         -         3,980
 Recoveries on resolved investments (note 4)                  1,094    -       1,094         49,672        94,105    143,777
 Reversal of performance fees previously recognised (note 4)  (6,623)  6,623   -             -             -         -
 Reimbursement of deployed capital                            126      13      139           901           -         901
 Proceeds from litigation funding assets                      (1,220)  (13)    (1,233)       (23,686)      (31,136)  (54,821)
 Foreign exchange gain                                        (350)    (849)   (1,198)       (2,043)       (3,592)   (5,635)
 Balance as at end of period                                  21,852   65,151  87,003        28,824        59,377    88,201

 

 

 

Note 11. Contract costs - litigation contracts

 

                                      31 Dec 2025  30 Jun 2025
                                      $'000        $'000

 Litigation contracts - ongoing       10,383       39,786
 Litigation contracts - under appeal  8,654        8,202
                                      19,037        47,988

 

There are a small number of legacy investments which are still being recorded
under AASB 15 Revenue from Contracts with Customers due to the timing the
contracts were entered into. These are expected to resolve in the short to
medium term.

 

Reconciliation of litigation contract costs

Reconciliation of the contract costs at the beginning and end of the current
period and previous financial year are set out below:

 

                                  31 Dec 2025  30 Jun 2025
                                  $'000        $'000
 Balance at 1 July                47,988       42,072
 Additions during the period      2,175        11,384
 Realisations of contract assets  (31,126)     (5,468)
 Balance as at end of period      19,037       47,988

 

Additions during the year relate to matters that progressed to trial, which
required significant investment in their final stages.

 

The Group has recognised impairment losses of $nil (June 2025: $5,468) in
profit or loss on contract costs for the period ended 31 December 2025.

 

 

Note 12. Investments

 

                                                                        31 Dec 2025                              30 Jun 2025
                                                                        LCM       Fund      Consolidated  LCM           Fund      Consolidated
                                                                        $'000     $'000     $'000         $'000         $'000     $'000

 At start of period                                                     124,839   162,896   287,735       202,913       262,300   465,213
 Deployments                                                            22,613    26,878    49,491        35,969        60,165    96,134
 Capital realised during the period (note 4)                            (7,577)   (20,057)  (27,635)      (27,485)      (72,649)  (100,134)
 Fair value removal on concluded investments (note 4)                   2,325     7,063     9,389         (49,020)      (44,997)  (94,017)
 Fair value write down on case losses under appeal (note 4)             (60,351)  (39,107)  (99,458)      (44,536)      (41,773)  (86,309)
 Fair value movement on pre-hearing/trial ongoing investments (note 4)  (3,283)   (5,185)   (8,468)       (6,824)       (21,292)  (28,115)
 Foreign exchange movements                                             (2,416)   (4,908)   (7,324)       13,820        21,142    34,962
 Balance as at end of period                                            76,151    127,579   203,729       124,839       162,896   287,735

 

 

Investments are financial instruments that relate to the provision of capital
in connection with legal finance. The Group fund through both direct
investments as well as using third party capital via a fund management model.
The table above sets forth the changes in litigation funding assets at the
beginning and end of the relevant reporting
periods.
 

 

 

Note 13. Trade and other payables

                   Consolidated
                   31 Dec 2025  30 Jun 2025
                   $'000        $'000
  Trade payables   23,512       10,227
  Other payables   159          281
                   23,672       10,508

 

 

Note 14. Borrowings

 

             Consolidated
             31 Dec 2025  30 Jun 2025
             $'000        $'000
 Borrowings  93,790       77,747
             93,790       77,747

 

 Reconciliation of borrowings of LCM:
                                                    31 Dec 2025    30 Jun 2025
                                                    $'000          $'000
  Balance 1 July                                    77,747         61,917
  Proceeds from borrowings                          15,666         25,039
 Non-cash interest and borrowing costs capitalised  4,214          -
  Repayment of borrowings                           -              (12,864)
  Payments for borrowing costs                      (694)          (487)
 Non-cash borrowing costs                           (2,185)        -
  Net accrued interest                              (3)            5
  Amortisation                                      419            611
 Refinance - foreign exchange movements             -              1,522
 Foreign exchange movements                         (1,374)        2,005
                                                    93,790         77,747

 

 

On 2 December 2024, LCM refinanced its credit facility with Northleaf Capital
Partners for an initial amount of US$75,000,000, AUD equivalent of
$112,442,000(1) (the "Facility"), with a potential to upsize by a further
US$75,000,000 (total US$150,000,000, AUD equivalent $224,885,000).

 

Interest is calculated by reference to the applicable currency benchmark,
being the US Federal Funds Rate for USD drawings, the Bank Bill Swap Reference
Rate (BBSY) for AUD drawings, and SONIA for GBP drawings (with fallback to the
Bank of England base rate), together with a 5.25% margin.

 

The Facility has an overall term of four years and is secured against LCM's
assets. As at 31 December 2025, LCM's outstanding utilisation amounted to
US$13,032,000 on the initial credit facility, an AUD equivalent of
$19,538,000(1).

 

LCM agreed to various debt covenants including a minimum effective net
tangible worth, borrowings as a percentage of effective net tangible worth,
minimum liquidity, a minimum consolidated EBIT and a minimum multiple of
invested capital on concluded contract assets over a specified period.

 

LCM incurred costs in relation to arranging the Facility of $3,671,000 which
were reflected transactions costs and will be amortised over the 4 year term
of the borrowings. As at 31 December 2025, $3,337,000 of these loan
arrangement fees remained outstanding.

 

 1 Converted at the functional currency spot rates of exchange at the
reporting date
 

 

 

 

Note 15.                Financial liabilities related to
third-party interests in consolidated entities

 

 

                                                                        31 Dec 2025  30 Jun 2025
                                                                        $'000        $'000
 Balance 1 July                                                         226,538      264,950
 Proceeds - capital contributions from Limited Partners                 38,145       67,106
 Payments - distributions to Limited Partners                           -            (33,959)
 Movement on financial liabilities related to third-party interests in  (51,098)     (90,133)
 consolidated entities (note 4)
 Non-cash movements in third-party assets and liabilities               (6,811)      9,705
 Foreign exchange movements                                             (728)        8,869
 Balance as at end of period                                            206,046      226,538

 

 

 

Note 16. Equity - issued capital

 

                                                               31 Dec 2025  30 Jun 2025  31 Dec 2025  30 Jun 2025
                                                               Shares       Shares       $'000        $'000
 Ordinary shares - fully paid                                  103,136,382  102,690,913  62,147       61,494
 Ordinary shares - loan share plan and Employee Benefit Trust  11,144,917   11,590,384   (860)        (860)
                                                               114,281,297  114,281,297  61,287       60,634

                                                               31 Dec 2025               30 Jun 2025
 Movements in ordinary share capital                           Shares       $'000        Shares       $'000
 Balance at 1 July                                             102,690,913  61,494       104,118,534  69,990
 Options exercised                                             445,467      652          740,764      1,359
 Share Buy-Back Programme (treasury shares)                    -            -            (2,168,385)  -
 Treasury shares cancelled                                     -            -            -            (9,854)
 Balance at period end                                         103,136,380  62,147       102,690,913  61,494

 

Movements in ordinary shares issued under loan share plan ('LSP') and held by
Employee Benefit Trust:

 

                        31 Dec 2025         30 Jun 2025
                        Shares      $'000   Shares      $'000
 Balance at 1 July      11,590,384  (860)   12,331,148  -
 Options exercised      (445,467)   -       (666,547)   -
 LSPs exercised         -           -       (858,736)   -
 LSPs purchased by EBT  -           -       784,519     (860)
 Balance at period end  11,144,917  (860)   11,590,384  (860)

 

Reconciliation of ordinary shares issued under LSP:

                                                                                 31 Dec 2025  30 Jun 2025
 Total shares allocated under existing LSP arrangements with underlying LSP      6,550,366    6,642,872
 shares (note 20)
 Less shares allocated under existing LSP arrangements without underlying LSP    (128,961)    (221,467)
 shares (note 20)
 Shares held by LCM Employee Benefit Trust for future allocation under employee  4,723,512    5,168,979
 share and option plans
                                                                                 11,144,917   11,590,384

 

Ordinary shares

Ordinary shares entitle the holder to participate in dividends and the
proceeds on the winding up of the Company in proportion to the number of and
amounts paid on the shares held. The fully paid ordinary shares have no par
value and the Company does not have a limited amount of authorised capital.

 

On a show of hands every member present at a meeting in person or by proxy
shall have one vote and upon a poll each share shall have one vote.

 

Ordinary shares - under loan share plan ('LSP')

The Company has an equity scheme pursuant to which certain employees may
access a LSP. The acquisition of shares under this LSP is fully funded by the
Company through the granting of a limited recourse loan. The shares under LSP
are restricted until the loan is repaid. The underlying options within the LSP
have been accounted for as a share-based payment. Refer to note 20 for further
details. When the loans are settled the shares are reclassified as fully paid
ordinary shares and the equity will increase by the amount of the loan repaid.

 

Ordinary shares - held by Employee Benefit Trust

The Employee Benefit Trust ('EBT')  holds performance related shareholdings
awarded to former executive which did not vest. The Trust holds 4,723,512
shares which remain unallocated as at 31 December 2025 (June 2025: 5,168,979).

 

Ordinary shares - partly paid

As at 31 December 2025, there are currently 1,433,022 partly paid shares
issued at an issue price of $0.17 per share. No amount has been paid up and
the shares will become fully paid upon payment to the Company of $0.17 per
share. As per the terms of issue, the partly paid shares have no maturity date
and the amount is payable at the option of the holder.

 

Partly paid shares entitle the holder to participate in dividends and the
proceeds of the Company in proportion to the number of and amounts paid on the
shares held. The partly paid shares do not carry the right to participate in
new issues of securities. Partly paid shareholders are entitled to receive
notice of any meetings of shareholders. The partly paid shareholders are
entitled to vote in the same proportion as the amounts paid on the partly paid
shares bears to the total amount paid and payable.

 

Capital risk management

The Group's objectives when managing capital is to safeguard its ability to
continue as a going concern, so that it can provide returns for shareholders
and benefits for other stakeholders and to maintain an optimum capital
structure to reduce the cost of capital.

 

Capital is regarded as total equity as recognised in the statement of
financial position.

 

In order to maintain or adjust the capital structure, the Group may adjust the
amount of dividends paid to shareholders, return capital to shareholders,
issue new shares or sell assets to reduce debt.

 

The capital risk management policy remains unchanged from the 30 June 2025
Annual Report.

 

Note 17. Equity - dividends

 

                                                                     31 Dec 2025  30 Jun 2025
                                                                     $'000        $'000
 Ordinary dividend paid (December 2025: nil, June 2025: 1.25 cents)  -            2,680

 

Franking credits

The franking credits available to the Group as at 31 December 2025 are $5,000
(June 2025: $5,000).

 

Note 18. Fair value measurements

 

The fair value measurements used for all assets and liabilities held by the
Group listed below are level 3:

 

 Assets                                                                  31 Dec 2025  30 Jun 2025
 Litigation funding assets                                               $'000        $'000
    APAC                                                                 87,831       81,220
    EMEA                                                                 115,898      206,515
 Total Level 3 assets                                                    203,729      287,735

 Liabilities
 Financial liabilities related to third-party interests in consolidated  206,046      226,538
 entities
 Total Level 3 liabilities                                               206,046      226,538

 

 

Refer note 12 for movements in level 3 assets and note 15 for movements in
level 3 liabilities. There were no transfers into or out of level 3 during the
period ended 31 December 2025.

 

As at 31 December 2025, the financial liability due to third-party interests
is $206,046,000 (June 2025: $226,538,000), recorded at fair value as
represented in note 15. Amounts included in the consolidated statement of
financial position represent the fair value of the third-party interests in
the related financial assets and the amounts included in the consolidated
statement of profit or loss and other comprehensive income represent the
third-party share of any gain or loss during the period, see note 3.

 

 

Sensitivity of Level 3 Valuations

The Group's fair value policy provides for ranges of percentages to be applied
against the risk adjustment factor to more than 159 discrete objective
litigation events. The tables below set forth each of the key unobservable
inputs used to value the Group's LFA assets and the applicable ranges and
weighted average by relative fair value for such inputs.

 

The Group implemented a new valuation methodology for LFA assets during the
year ended 30 June 2023. LFA assets are fair valued using an income approach
which is the technique adopted for LFA Assets. Under the income approach,
future cash flows associated with; cash out flows, including investments and
deployments, and cash inflows such as settlements or resolutions, are
converted to a single current (discounted) amount, reflecting current market
expectations about those future amounts. That is, the amount that could
reasonably be expected to be paid to acquire the asset at that point in time.
In developing our framework we also looked to Industry peers for alignment in
methodology, the benefit being that adopting a similar methodology provides a
level of comparability. Similar to industry peers, the framework developed
applied probabilities based on observable milestones for each investment
within the portfolio as well as making informed assumptions around inputs such
as discount rates, timing and risk factors, all of which are considered Level
3 inputs. In cases where cash flows are denominated in a foreign currency,
forecasts are developed in the applicable foreign currency and translated to
AUD dollars.

 

A Discounted Cash Flow approach is then applied to each underlying investment
on an individual basis to arrive at a net present value of the future expected
cash flows.

 

The cash flow forecast is updated each reporting period, based on the best
available information on progress of the underlying matter at the time. These
objective events could include, among others:

 -  Stage of the investment
 -  ongoing developments
 -  progress
 -  recovery or sovereign risk
 -  legal team expertise
 -  other factors impacting the expected outcome

 

Each reporting period, the updated risk-adjusted cash flow forecast is then
discounted at the then current discount rate to measure fair value. The
discount rate includes an applicable risk-free rate and credit spread to
incorporate both market and idiosyncratic asset-class risk.

 

The Group's fair value policy provides for ranges of percentages to be applied
against the risk adjustment factor to more than 159 discrete objective
litigation events. The tables below set forth each of the key unobservable
inputs used to value the Group's LFA assets and the applicable ranges and
weighted average by relative fair value for such inputs.

 

31 December 2025

 

 Item                      Valuation technique   Unobservable Input(1)                                                      Min     Max           Weighted average
 Litigation funding asset  Discounted cash flow  Discount rate                                                              9.6%    10.6%         10.11%
                                                 Duration (years)                                                           2.50    8.08          5.44
                                                 Adjusted risk premium                                                      (50%)   80%           (6%)

                                                 Adjusted risk premium - case milestone                                     Min(2)  Max(2)  ( )   Weighted average  % of portfolio(3)
                                                 Pre-commencement & commenced                                               0%      0%            0%                51%
                                                 Pleadings                                                                  0%      10%           4%                6%
                                                 Discovery & evidence                                                       10%     20%           14%               15%
                                                 Significant ruling or other objective event prior to trial court judgment  20%     65%           50%               1%
                                                 Settlement                                                                 90%     90%           0%                0%
                                                 Trial court judgment or tribunal award                                     (100%)  75%           (39%)             9%
                                                 Appeal judgment                                                            (100%)  80%           (32%)             14%
                                                 Enforcement                                                                (50%)   80%           (20%)             4%

 

30 June 2025

 

 Item                      Valuation technique   Unobservable Input(1)                                                      Min     Max           Weighted average
 Litigation funding asset  Discounted cash flow  Discount rate                                                              10.2%   10.9%         10.6%
                                                 Duration (years)                                                           2.42    7.67          5.45
                                                 Adjusted risk premium                                                      (60%)   80%           10%

                                                 Adjusted risk premium - case milestone                                     Min(2)  Max(2)  ( )   Weighted average  % of portfolio(3)
                                                 Pre-commencement & commenced                                               0%      0%            0%                56%
                                                 Pleadings                                                                  0%      10%           2%                9%
                                                 Discovery & evidence                                                       10%     20%           15%               10%
                                                 Significant ruling or other objective event prior to trial court judgment  20%     65%           64%               6%
                                                 Settlement                                                                 90%     90%           0%                0%
                                                 Trial court judgment or tribunal award                                     (100%)  75%           (22%)             8%
                                                 Appeal judgment                                                            (100%)  80%           (46%)             8%
                                                 Enforcement                                                                80%     80%           80%               3%

 

1 Minimum and maximum within each cohort represent the actual adjusted risk
premiums applied in the period

2 Percentage of portfolio represents the percentage of the book within the
cohort

 

 

Note 19. Contingent liabilities

 

Potential clawback of Fund 1 performance fees

The Group is entitled to receive performance fees when investment returns of
the Funds exceed specified performance thresholds. These performance fees are
calculated by reference to realised investment outcomes and are distributed
before the final outcome of all investments within the fund is known.

 

In certain circumstances, fund documentation provides a mechanism under which
performance fees previously distributed may be required to be returned. This
is intended to ensure that, over the life of the fund, performance fees
ultimately retained by the Group are aligned with the overall performance of
the fund and the outcomes achieved for investors. Any requirement to return
performance fees is conditional on specific future events. As a result, the
existence and timing of any obligation to repay performance fees is uncertain.

 

The Group has assessed its potential exposure having regard to the contractual
terms of the fund documentation, and based on current information and
reasonable assumptions, should the relevant conditions arise and a repayment
be required, the amount of performance fees that could potentially be subject
to clawback is estimated to range between approximately $12 million and $17
million.

 

In forming this estimate, the Group has considered the current status of the
Fund's remaining investments and historic performance, however the outcome
remains dependent on future events not wholly within the Group's control.

 

Under-insured adverse costs exposure

In certain jurisdictions, litigation funding arrangements entered into by the
Group include undertakings to meet adverse costs awarded to the successful
party in the event that funded litigation is unsuccessful. The occurrence and
quantum of any adverse cost award is inherently uncertain and dependent on the
outcome of litigation proceedings, and accordingly it is not possible to
predict whether or when such costs may be incurred.

 

The Group maintains adverse costs insurance arrangements (commonly referred to
as after-the-event or ATE insurance) which mitigate the financial impact of
adverse cost awards. While these arrangements substantially reduce the Group's
exposure, a residual risk may exist in respect of adverse cost awards that may
not be fully covered by insurance.

 

The recent outcome in the Queensland Electricity class action (a funded matter
where the claim was unsuccessful and adverse costs were quantified by the
Federal Court of Australia in late 2025 at approximately A$32.4 million in
total) highlighted the potential for ATE insurance to be insufficient to fully
cover such awards in certain cases, resulting in a material uninsured exposure
for the Group and/or relevant fund investors. In light of this development,
the Group has undertaken a comprehensive review of its other currently funded
investments to reassess the adequacy of existing ATE insurance arrangements
and the potential residual risks of under-insurance across the portfolio.

 

As at the reporting date, based on the Group's assessment of its currently
funded investments, the potential exposure to adverse costs not covered by
insurance remains contingent on the outcome of litigation matters and cannot
be reliably predicted or measured with sufficient certainty for recognition as
a provision. Based on current information and reasonable assumptions, should
one or more funded matters be unsuccessful and adverse cost awards be made
which are not fully covered by insurance, the Group estimates that the
potential under-insured adverse cost exposure for LCM could range between
approximately A$4 million and A$8 million.

 

In forming this assessment, the Group has considered the status of funded
proceedings, applicable insurance arrangements (including policy limits and
any lessons from recent cases such as the Queensland Electricity class
action), historical experience, jurisdictional factors, and the inherent
uncertainties in litigation outcomes.

 

 

Note 20. Share-based payments

 

The share-based payment expense for the period was $389,000 (December 2024:
$590,000).

 

Loan Funded Share Plans ('LSP')

As detailed in note 16, the Group has an equity scheme pursuant to which
certain employees may access a LSP. The shares under LSP are issued at the
exercise price by granting a limited recourse loan. The LSP shares are
restricted until the loan is repaid. Options under this scheme can be granted
without an underlying LSP share until they have been exercised and on this
basis, do not form part of the Group's issued share capital. The underlying
options have been accounted for as a share-based payments. The options are
issued over a 1-3 year vesting period. Vesting conditions include satisfaction
of customary continuous employment with the Group and may include a share
price hurdle.

 

During the period the Group granted nil (June 2025: nil) shares under the LSP.

 

Set out below are summaries of shares/options granted under the
LSP:

 

31 December
2025

 Grant date   Expiry date    Exercise    Balance at the start of the period    Granted    Exercised    Expired/    Balance at the end of the period

Price
forfeited/

other
 04/12/2017  04/12/2027     $0.60       2,000,000                             -          -            -            2,000,000
 19/11/2018  25/11/2028     $0.47       1,595,058                             -          -            -            1,595,058
 03/12/2018  03/12/2028     $0.89       100,000                               -          -            -            100,000
 01/11/2019  01/11/2029     £0.7394     918,694                               -          -            -            918,694
 13/10/2020  13/10/2030     £0.6655     458,224                               -          -            -            458,224
 27/10/2021  27/10/2031     £1.06       1,349,429                             -          -            -            1,349,429
 27/10/2021  27/10/2031     £1.06       99,037(1)                             -          -            (5,452)      93,585(1)
 27/10/2021  27/10/2031     £1.14       122,430(1)                            -          -            (87,054)     35,376(1)
                                        6,642,872                             -          -            (92,506)     6,550,366

 (1)Options granted without an underlying LSP share until exercised ie, do not
 form part of the Group's issued share capital

 

Deferred Bonus Share Plan ('DBSP')

The Company has in place a DBSP. Options granted under the DBSP reflect past
performance and are in the form of nil cost options and will vest in three
equal tranches from the date of issue and are subject to continued employment
over the three year period.

 

In addition, the Options granted under the DBSP are subject to malus and
clawback provisions. In the event of a change of control of the Company,
unvested awards will vest to the extent determined by the Board, taking into
account the proportion of the period of time between grant and the normal
vesting date that has elapsed at the date of the relevant event.

 

During the period the Group granted nil (June 2025: 532,235) options under the
DBSP.

 

Set out below are summaries of options granted under the DBSP:

 

31 December 2025

 Grant date  Expiry date  Exercise  Balance at the start of the period  Granted  Exercised  Expired/     Balance at the end of the period

Price
forfeited/

other
 07/10/2022  07/10/2032   $0.00     434,967                             -        (183,661)  (66,764)     184,542
 04/10/2023  04/10/2033   $0.00     547,832                             -        (125,478)  (89,335)     333,019
 04/10/2024  04/10/2034   $0.00     532,235                             -        (136,328)  (20,416)     375,491
                                    1,515,034                           -        (445,467)  (176,515)    893,052

 

Executive Long Term Incentive Plan ('LTIP')

The Company has in place an Executive LTIP. Options granted under the LTIP in
the form of nil cost options and are subject to performance conditions which
require the growth of Funds under Management ('FuM') over a five year
performance period.

 

During the period, all LTIPs lapsed as the performance conditions were not
satisfied.

 

31 December 2025

 

  Grant date    Expiry date    Exercise    Balance at the start of the period    Granted    Exercised    Expired/    Balance at the end of the period

Price
forfeited/

other
 07/10/2022    07/10/2032     $0.0000     5,671,516                             -          -            (5,671,516)  -
                                          5,671,516                             -          -            (5,671,516)  -

 

 

Note 21. Events after the reporting period

 

On 12 January 2026, the Group announced a positive development in its
international arbitration claim against the Republic of Poland, where the
Singapore court rejected Poland's application to set aside the Energy Charter
Treaty award.

On 2 February 2026, the Group announced an increase in its credit facility
together with an extension of the debt covenant waiver from its lender.

On 11 March 2026, the Group announced that its funded party had been
successful in the High Court of Australia in a trademark dispute claim in
which LCM had invested A$3.3 million. The matter will now proceed to the Full
Court for the quantification of costs and damages.

On 17 March 2026, the Group announced that an adverse judgment had been
delivered in an Australian commercial litigation claim funded by the Group
with A$1.4 million of shareholder capital. The Group is reviewing the judgment
and considering its options.

The Strategic Review, which was commenced in September 2025, continues to
progress.

 

 

Directors' Declaration

 

In the directors' opinion:

 

·      the attached financial statements and notes comply with the
Corporations Act 2001, Australian Accounting Standards and other mandatory
professional reporting
requirements;

·      the attached financial statements and notes comply with
International Financial Reporting Standards as issued by the International
Accounting Standards Board as described in note 2 to the financial statements;

·      the attached financial statements and notes give a true and fair
view of the consolidated entity's financial position as at 31 December 2025
and of its performance for the period ended on that date;

·      there are reasonable grounds to believe that the company will be
able to pay its debts as and when they become due and payable.

 

Signed in accordance with a resolution of
directors.

 

On behalf of the
directors

 

 

 

 

 

Director

Dated this 31st day of March 2026

 

-end-

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  IR JMMITMTAJBTF



            Copyright 2019 Regulatory News Service, all rights reserved

Recent news on Litigation Capital Management

See all news